Roberto Brugnoli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes. A Long-Term Follow-up Study	JOURNAL OF PERSONALIZED MEDICINE	2022
Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders	JOURNAL OF PERSONALIZED MEDICINE	2022
Accuracy of self-assessment of real-life functioning in schizophrenia	NPJ SCHIZOPHRENIA	2021
Cerebral cortical thickness and gyrification changes in first-episode psychoses and multi-episode schizophrenia	ARCHIVES ITALIENNES DE BIOLOGIE	2021
PON1 polymorphisms can predict generalized anxiety and depressed mood in patients with multiple chemical sensitivity	PERSONALIZED MEDICINE	2021
Current Clinical Psychopharmacology in Borderline Personality Disorder	CURRENT NEUROPHARMACOLOGY	2021
International Expert Opinions and Recommendations on the Use of Melatonin in the Treatment of Insomnia and Circadian Sleep Disturbances in Adult Neuropsychiatric Disorders	FRONTIERS IN PSYCHIATRY	2021
Economic Impact of Schizophrenia from a Hospital and Social Security System Perspective in Italy	CLINICAL DRUG INVESTIGATION	2021
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients	WORLD PSYCHIATRY	2020
The association between insight and depressive symptoms in schizophrenia. Undirected and Bayesian network analyses	EUROPEAN PSYCHIATRY	2020
Evaluation and management of insomnia in clinical practice and in the time of CoViD-19 in Italy. Expert consensus and task-force recommendations from five scientific societies [Valutazione e trattamento dell'insonnia nella pratica clinica e ai tempi di CoViD-19 in Italia. Raccomandazioni del panel di esperti e della task-force integrata di cinque società scientifiche]	RIVISTA DI PSICHIATRIA	2020
Expert opinions and consensus recommendations for the evaluation and management of insomnia in clinical practice. joint statements of five Italian scientific societies	FRONTIERS IN PSYCHIATRY	2020
Long-Acting Injectable (LAI) aripiprazole formulations in the treatment of schizophrenia and bipolar disorder: a systematic review	CLINICAL DRUG INVESTIGATION	2019
Drug Treatment Of Trichotillomania (Hair-Pulling Disorder), Excoriation (Skin-Picking) Disorder, And Nail-Biting (Onychophagia)	CURRENT NEUROPHARMACOLOGY	2019
Disorganization and cognitive impairment in schizophrenia: new insights from electrophysiological findings	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY	2019
Placebo effect in obsessive-compulsive disorder (OCD). placebo response and placebo responders in OCD: The trend over time	CURRENT NEUROPHARMACOLOGY	2019
Familial aggregation of MATRICS consensus cognitive battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives	PSYCHOLOGICAL MEDICINE	2018
Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate	HUMAN PSYCHOPHARMACOLOGY	2018
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses	SCHIZOPHRENIA RESEARCH	2018
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia a network analysis	JAMA PSYCHIATRY	2018